Metraipolis › archive › dc_fdb96de3acc0
Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis — Europe PMC PMID:42621905
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42621905
- DOI
- 10.3389/fmed.2026.1867718
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T07:56:07.944Z
- SHA-256 of the archived text
58b454c52687a5cbc0717fcd641efb583585e9a9d1e78aa2bd563ba12249ba33- Stable URL of this page
https://metraipolis.com/documento/dc_fdb96de3acc0
How to cite
Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis — Europe PMC PMID:42621905 — Europe PMC (en), https://europepmc.org/article/MED/42621905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdb96de3acc0 (Metraipolis archive dc_fdb96de3acc0, sha256 58b454c52687a5cbc0717fcd641efb583585e9a9d1e78aa2bd563ba12249ba33)
BibTeX
@misc{dcfdb96de3acc0,
title = {Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis — Europe PMC PMID:42621905},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42621905},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdb96de3acc0; sha256 58b454c52687a5cbc0717fcd641efb583585e9a9d1e78aa2bd563ba12249ba33},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42621905. Agents can read the archived copy with the MCP tool read_document.